NCT01425541View on ClinicalTrials.gov

Assessment of the Sensitivity of the Hypothalamic GnRH Pulse Generator to Estradiol and Progesterone Inhibition

NAActive, not recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 30, 2000

Primary Completion Date

August 31, 2025

Study Completion Date

August 31, 2025

Conditions
HyperandrogenemiaPolycystic Ovary Syndrome (PCOS)
Interventions
DRUG

estrace

0.5-1 mg once a day PO for 7 days

DRUG

Progesterone

20 mg/ml, 25-100 mg, Three times a day at 0700, 1500, and 2300 hr for 7 days

Trial Locations (1)

22908

Center for Research in Reproduction, Charlottesville

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

University of Virginia

OTHER